We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRT icon
1001
Copart
CPRT
$26.8B
– –
-817
Closed -$36K
CPRI icon
1002
CALL
Capri Holdings
CPRI
$1.77B
– –
-157
Closed -$3K
CRC icon
1003
California Resources
CRC
$4.75B
– –
-682
Closed -$36K
CRDO icon
1004
PUT
Credo Technology Group
CRDO
$50B
– –
-10
Closed -$1K
CRGY icon
1005
Crescent Energy
CRGY
$3.98B
– –
-136
Closed -$1K
CRM icon
1006
CALL
Salesforce
CRM
$158B
– –
-40
Closed -$9K
CRNC icon
1007
Cerence
CRNC
$391M
– –
-137
Closed -$1K
CROX icon
1008
Crocs
CROX
$6.26B
– –
-577
Closed -$48K
CRWD icon
1009
CrowdStrike
CRWD
$226B
– –
-15,476
Closed -$1.9M
CRWD icon
1010
PUT
CrowdStrike
CRWD
$226B
– –
-24
Closed -$2K
CRWS icon
1011
Crown Crafts
CRWS
$32M
$0 ﹤0.01%
+100
New +$278
CSTM icon
1012
Constellium
CSTM
$4B
– –
-14
Closed –
CSX icon
1013
CSX Corp
CSX
$92.8B
– –
-720
Closed -$25K
CTRA
1014
DELISTED
Coterra Energy
CTRA
– –
-14
Closed –
CUK
1015
DELISTED
Carnival PLC
CUK
– –
-100
Closed -$2K
CVGW
1016
DELISTED
Calavo Growers
CVGW
$0 ﹤0.01%
10
-341
-97% -$7.56K
HELP
1017
Cybin Inc
HELP
$712M
$0 ﹤0.01%
100
-50,844
-100% -$327K
CYH icon
1018
Community Health Systems
CYH
$410M
$0 ﹤0.01%
+150
New +$504
CYTK icon
1019
CALL
Cytokinetics
CYTK
$10.5B
– –
-33
Closed -$1K
CZR icon
1020
CALL
Caesars Entertainment
CZR
$6.04B
– –
-41
Closed -$1K
DAL icon
1021
Delta Air Lines
DAL
$59.1B
– –
-14
Closed –
DAR icon
1022
CALL
Darling Ingredients
DAR
$10B
– –
-102
Closed -$3K
DAR icon
1023
Darling Ingredients
DAR
$10B
– –
-1,471
Closed -$45K
DASH icon
1024
DoorDash
DASH
$92.1B
– –
-6,000
Closed -$1.63M
DBI icon
1025
Designer Brands
DBI
$311M
– –
-14
Closed -$67
39 40
41
42 43

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.